Physician profile
Christopher Glezos
NPI 1922341601
$39,029.05
in general payments reported to CMS, 2019-2025
12 companies · $18K in 2025
The $18K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $116 · 2021: $282 · 2022: $99.80 · 2023: $1,010 · 2024: $19K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $35K · Food and Beverage: $1,932 · Travel and Lodging: $1,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $35,456.25 |
| Food and Beverage | $1,932.28 |
| Travel and Lodging | $1,023.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $37,468.86 | 2021-2025 | Velys, Attune, Actis |
| Depuy Synthes Sales INC. | $806.19 | 2019-2025 | Attune |
| Stryker Corporation | $427.76 | 2019-2023 | Mako, Tritanium, Insignia |
| Urgo Medical North America, LLC | $100.11 | 2023 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Ethicon US, LLC | $64.55 | 2024-2025 | Surgicel Nu-Knit, Stratafix, Dermabond |
| Heraeus Medical, LLC. | $46.69 | 2022-2023 | Palacos |
| Smith+Nephew, INC. | $31.72 | 2025 | Pico 14 |
| Omnilife Science, INC | $31.30 | 2022 | |
| Horizon Therapeutics Plc | $20.49 | 2021 | |
| Becton, Dickinson and Company | $16.60 | 2025 | Surgiphor |
| Boston Scientific Corporation | $14.78 | 2025 | Wavewriter Alpha Prime 16 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$225,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Glezos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.